NL7217841A - - Google Patents
Info
- Publication number
- NL7217841A NL7217841A NL7217841A NL7217841A NL7217841A NL 7217841 A NL7217841 A NL 7217841A NL 7217841 A NL7217841 A NL 7217841A NL 7217841 A NL7217841 A NL 7217841A NL 7217841 A NL7217841 A NL 7217841A
- Authority
- NL
- Netherlands
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25585572A | 1972-05-22 | 1972-05-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL7217841A true NL7217841A (cg-RX-API-DMAC7.html) | 1973-11-26 |
Family
ID=22970143
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL7217841A NL7217841A (cg-RX-API-DMAC7.html) | 1972-05-22 | 1972-12-29 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US3763147A (cg-RX-API-DMAC7.html) |
| JP (1) | JPS5339425B2 (cg-RX-API-DMAC7.html) |
| BE (1) | BE792624A (cg-RX-API-DMAC7.html) |
| FR (1) | FR2185402B2 (cg-RX-API-DMAC7.html) |
| LU (1) | LU66776A1 (cg-RX-API-DMAC7.html) |
| NL (1) | NL7217841A (cg-RX-API-DMAC7.html) |
| SU (1) | SU576956A3 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3227598A1 (de) * | 1982-07-22 | 1984-01-26 | Schering AG, 1000 Berlin und 4709 Bergkamen | 7(alpha)-acylthio-15.16-methylen-3-oxo-17(alpha)-pregna-1.4-dien-21,17-carbolactone, verfahren zu ihrer herstellung und verwendung als arzneimittel |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL166267C (nl) * | 1968-03-22 | 1981-07-15 | Merck & Co Inc | Werkwijze ter bereiding van farmaceutische preparaten, de onder toepassing daarvan verkregen gevormde voort- brengselen, alsmede werkwijze ter bereiding van 6,7-methyleen-20-spirox-4-en-3-onderivaten met aldoste- ron remmende werking. |
-
0
- BE BE792624D patent/BE792624A/xx unknown
-
1972
- 1972-05-22 US US00255855A patent/US3763147A/en not_active Expired - Lifetime
- 1972-12-28 JP JP399673A patent/JPS5339425B2/ja not_active Expired
- 1972-12-28 FR FR7246667A patent/FR2185402B2/fr not_active Expired
- 1972-12-28 LU LU66776A patent/LU66776A1/xx unknown
- 1972-12-29 SU SU7201870515A patent/SU576956A3/ru active
- 1972-12-29 NL NL7217841A patent/NL7217841A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2185402B2 (cg-RX-API-DMAC7.html) | 1976-03-05 |
| JPS5339425B2 (cg-RX-API-DMAC7.html) | 1978-10-21 |
| BE792624A (fr) | 1973-06-12 |
| LU66776A1 (cg-RX-API-DMAC7.html) | 1973-07-18 |
| JPS5058053A (cg-RX-API-DMAC7.html) | 1975-05-20 |
| FR2185402A2 (cg-RX-API-DMAC7.html) | 1974-01-04 |
| SU576956A3 (ru) | 1977-10-15 |
| US3763147A (en) | 1973-10-02 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BN | A decision not to publish the application has become irrevocable |